KyDo Therapeutics
PrivateLast Round
Grant
Jan 1, 2026
Total Funding Raised
$4.81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KyDo Therapeutics Comparables
Compare KyDo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adoram Therapeutics | 85% | |
| Antares Therapeutics | 82% | |
| Hyku Biosciences | 80% |
KyDo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2026 | ||||
| Seed | Sep 16, 2025 |
KyDo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TU capital | Seed |
| KHAN Technology Transfer Fund II | Seed |
| VORNvc | Seed |
| State of North Rhine-Westphalia | Grant |
| i&i Prague | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Received funding from the European Union and the State of North Rhine-Westphalia.
- Sep 16, 2025
$5.28M round led by i&i Biotech Fund I
KyDo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KyDo Therapeutics's valuation, stock price, and market status.
Is KyDo Therapeutics a public or private company?
KyDo Therapeutics is a private company.
What is the current stock price of KyDo Therapeutics?
KyDo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is KyDo Therapeutics worth (valuation)?
Valuation information for KyDo Therapeutics is not publicly available.
Can I buy KyDo Therapeutics stock?
KyDo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KyDo Therapeutics's last funding round?
KyDo Therapeutics's most recent funding round was Seed on September 16, 2025.
Who are the main investors in KyDo Therapeutics?
Key investors in KyDo Therapeutics include i&i Prague.
Will KyDo Therapeutics IPO soon?
No public IPO plans have been announced for KyDo Therapeutics.
How can I track KyDo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KyDo Therapeutics's secondary market activity and sign up for updates.